EDISON, N.J., May 25 /PRNewswire/ -- Informed Medical Communications (IMC), a leading full-service provider of peer-to-peer medical forums and integrated medical communications for the bio-pharmaceutical industry, today announced its "Commitment to Compliance" initiative, responding to the FDA's new program to minimize misleading drug advertising and promotion. Recognizing the level of complexity the FDA's "Bad Ad Program" adds to pharmaceutical marketing, IMC issued a series of industry communications to reinforce its position on compliant dissemination of pharmaceutical product information. Additionally, IMC began a multi-faceted campaign to inform the industry regarding its longstanding compliance training policy for its elite team of Medical Moderators and other staff responsible for communications with healthcare professionals.
Steve Budd, IMC's CEO commented, "We're finding that with growing levels of compliance uncertainty in the market, our clients, now more than ever, are valuing the unique role and rigorous training of our Medical Moderators. I believe our 25 years without compliance violations is a testament to the strong role our Moderators play in ensuring compliance during peer-to-peer events." With growing challenges facing pharmaceutical marketers, IMC hopes the initiative will provide pharmaceutical customers with added comfort regarding IMC's low-risk, high-impact services for meeting brand objectives. As Jaime Nguyen, MD, IMC's Compliance Officer summarizes, "IMC's Moderated format for driving deep peer discussion mitigates risk for our clients and enables physicians to engage in germane dialogue on information and data that is on-label, current, and truthful."
About Informed Medical Communications
Informed Medical Communications (www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Dialogue Training, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.
|SOURCE Informed Medical Communications|
Copyright©2010 PR Newswire.
All rights reserved